Related content

Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates

By Griffioen Marieke   Borghi Martina   Schrier Peter   Osanto Susanne   Schadendorf Dirk  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 8, 2004-08 ,pp. : 715-722

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic Factors That Determine the Long-Term Survival of Patients with Unresectable Metastatic Melanoma

By Bedikian Agop   Johnson Marcella   Warneke Carla   Papadopoulos Nicholas   Kim Kevin   Hwu Wen-Jen   McIntyre Susan   Hwu Patrick  

Cancer Investigation, Vol. 26, Iss. 6, 2008-07 ,pp. : 624-633

Informa Healthcare

Access to resources Recommend Favorite

Isolated Tumor Cells and Long-Term Prognosis of Patients with Melanoma

By van Akkooi A.  

Annals of Surgical Oncology, Vol. 15, Iss. 5, 2008-05 ,pp. : 1547-1548

Springer Publishing Company

Access to resources Recommend Favorite

Enhancement of cytotoxic T-lymphocyte responses in patients with gastrointestinal malignancies following vaccination with CEA peptide–pulsed dendritic cells

By Matsuda Kenji   Tsunoda Takuya   Tanaka Hajime   Umano Yasukazu   Tanimura Hiroshi   Nukaya Ikuei   Takesako Kazutoh   Yamaue Hiroki  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 7, 2004-07 ,pp. : 609-616

Springer Publishing Company

Access to resources Recommend Favorite

Vaccination with p53-peptide–pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study

By Svane Inge   Pedersen Anders   Johnsen Hans   Nielsen Dorte   Kamby Claus   Gaarsdal Eva   Nikolajsen Kirsten   Buus Søren   Claesson Mogens  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 7, 2004-07 ,pp. : 633-641

Springer Publishing Company

Access to resources Recommend Favorite